Clinical Trials

13 trials registered for Crigler-Najjar syndrome type I

Baby Detect : Genomic Newborn Screening

NCT05687474N/ACentre Hospitalier Universitaire de Liege

Completed↗

Clinical Assessment Study in Crigler-Najjar Syndrome

NCT03078881N/AAudentes Therapeutics

Completed↗

Immunity Against AAV in Crigler Najjar Patient

NCT02302690N/AGenethon

Completed↗

Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)

NCT02051049N/ACellaion SA

Completed↗

Orlistat Treatment of Crigler-Najjar Disease

NCT00461799N/AUniversity Medical Center Groningen

Completed↗

Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)

NCT01765283Phase 1/2Cellaion SA

Completed↗

Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome

NCT06518005Phase 2Genethon

Recruiting↗

Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)

NCT06641154Phase 1/2Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare

Recruiting↗

Gene Therapy for Severe Crigler Najjar Syndrome

NCT03466463N/AGenethon

Recruiting↗

Gene Transfer Clinical Study in Crigler-Najjar Syndrome

NCT03223194Phase 1Audentes Therapeutics

Terminated↗

HepaStem Long-Term Safety Registry

NCT03343756N/ACellaion SA

Terminated↗

Hepatocyte Transplantation for Liver Based Metabolic Disorders

NCT01345578Phase 1Ira Fox

Terminated↗

New Phototherapy Device to Treat Patients With Crigler-Najjar Disease

NCT02356978N/AAssistance Publique - Hôpitaux de Paris

Unknown↗